Women with PMOS should get subsidised weight loss drugs, advocates say
10 Oct 2026, 04:55 AM

Women with PMOS should get subsidised weight loss drugs, advocates say

G
Guard News
@guardnews
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-labelGet our breaking news email, free app or daily news podcastWomen living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition. Continue reading...
Source Credit: theguardian.com
Read Full Story
2

Comments (0)

Login to join the conversation
More News
More News
Zelenskyy furious as Trump announces deal to buy Russian diesel
10 Oct 2026
Questions remain over Ebola patient who travelled across three nations undetected
10 Oct 2026
Malaysia PM Anwar’s 2027 budget spreads the goodies, but will it win over voters?
10 Oct 2026
Boy and father in critical condition after attack in own home by masked men
10 Oct 2026
Analysis: Trump's shock Russia deal highlights mounting pressure to curb fuel prices
10 Oct 2026
Inside Thailand’s cyanide murders and the search for its ‘most prolific serial killer’ in history
10 Oct 2026